Beth Israel Hospital

Vial welcomes Dr. Joseph Tauber to the team as Head of Ophthalmology Research

Retrieved on: 
Wednesday, March 23, 2022

SAN FRANCISCO, March 23, 2022 /PRNewswire/ -- The Vial Ophthalmology network has announced Dr. Joseph Tauber as their Head of Ophthalmology Research.

Key Points: 
  • SAN FRANCISCO, March 23, 2022 /PRNewswire/ -- The Vial Ophthalmology network has announced Dr. Joseph Tauber as their Head of Ophthalmology Research.
  • Dr. Tauber has been in the field for 32+ years, and is the Founder and CEO of Tauber Eye Center in Kansas City, MO.
  • The Vial Ophthalmology network officially launched in early 2022 with the mission of creating a network of top investigators enabled by Vial's central services.
  • In this role, Dr. Tauber will help grow Vial's Ophthalmology site network, while also lending his expertise to the Vial team as they create best practices around patient recruiting, training, and more.

Integrative Healthcare Symposium Honored Integrative Healthcare Visionary, Andrew Weil, MD

Retrieved on: 
Friday, February 18, 2022

Each year, the Symposium honors an integrative healthcare professional whose forward-thinking contributions have advanced their field of practice and their community.

Key Points: 
  • Each year, the Symposium honors an integrative healthcare professional whose forward-thinking contributions have advanced their field of practice and their community.
  • Notable past recipients include David Perlmutter MD, FACN, ABIHM, Joe Pizzorno, ND, Mark Hyman, MD, Mehmet Oz, MD, and Tieraona Low Dog, MD.
  • The Integrative Healthcare Symposium is an annual three-day conference featuring an exhibit hall and networking opportunities for integrative healthcare practitioners.
  • About Integrative Healthcare Symposium: The Integrative Healthcare Symposium brings together multi-disciplinary practitioners and healthcare professionals dedicated to improving patient outcomes and defining the future of integrative healthcare.

New Jersey primary care physician, Dr. Vishal Patel collaborates with Castle Connolly Private Health Partners to create a new concierge medical program, offering patients a more personalized approach to their care

Retrieved on: 
Wednesday, February 16, 2022

The concierge (membership-based) model continues to be a rewarding experience for physicians and patients alike.

Key Points: 
  • The concierge (membership-based) model continues to be a rewarding experience for physicians and patients alike.
  • Cultivating patient wellness and practicing preventative care are intrinsic to the approach of the concierge model.
  • The CCPHP health coaches work in tandem with Dr. Patel to help Members reach their individual health goals.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/new-jersey-primary-care-physici...
    SOURCE Castle Connolly Private Health Partners, LLC

vTail Healthcare Telecommunications Announces New Clinical Advisory Board Appointments for its Newest Channel - Dentistry

Retrieved on: 
Thursday, November 18, 2021

OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- vTail , the Healthcare Communications App connecting healthcare professionals directly to medical products companies, today announced an expansion of its Clinical Advisory Board with the appointment of four new members to its Dental Channel.

Key Points: 
  • OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- vTail , the Healthcare Communications App connecting healthcare professionals directly to medical products companies, today announced an expansion of its Clinical Advisory Board with the appointment of four new members to its Dental Channel.
  • vTail Chief Marketing Officer, Michael McCarthy, MBA, commented, "Developing this Clinical Advisory Board has been like building a dream team of Dentists, Specialists and Hygienistsit's the culmination of my 20+ years working in the professional dental arena.
  • I'm honored to have them on board and guiding us through the needs and wants of today's dental practitioners around the globe".
  • The four new members include:
    Wayne A. Aldredge, DMD, Periodontist - an internationally recognized, board certified periodontal surgeon and dental implantologist.

vTail Healthcare Telecommunications Announces New Clinical Advisory Board Appointments for its Newest Channel - Dentistry

Retrieved on: 
Thursday, November 18, 2021

OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- vTail , the Healthcare Communications App connecting healthcare professionals directly to medical products companies, today announced an expansion of its Clinical Advisory Board with the appointment of four new members to its Dental Channel.

Key Points: 
  • OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- vTail , the Healthcare Communications App connecting healthcare professionals directly to medical products companies, today announced an expansion of its Clinical Advisory Board with the appointment of four new members to its Dental Channel.
  • I'm honored to have them on board and guiding us through the needs and wants of today's dental practitioners around the globe".
  • The four new members include:
    Wayne A. Aldredge, DMD, Periodontist - an internationally recognized, board certified periodontal surgeon and dental implantologist.
  • vTail was selected as a Top 10 Clinical Communications & Collaboration Solution Provider for 2021 by MD Tech Review.For Media Enquiries, please contact: [email protected]

AXIM® Biotechnologies Appoints Joseph Tauber, MD, Chief Medical Officer and Chairman of its Medical Advisory Board

Retrieved on: 
Tuesday, September 21, 2021

SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, or the Company), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced that it has appointed Joseph Tauber, MD as Chief Medical Officer and Chairman of its Medical Advisory Board.

Key Points: 
  • SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (AXIM Biotech, or the Company), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced that it has appointed Joseph Tauber, MD as Chief Medical Officer and Chairman of its Medical Advisory Board.
  • Dr. Tauber has served on numerous scientific advisory boards and as the Ophthalmology representative at institutional investor-focused conferences.
  • Dr. Tauber is arguably among the worlds leading authorities on dry eye and ocular surface disease, including researching the causes, treating, and diagnosing patients with dry eye disease, said John W. Huemoeller II, AXIM Biotech Chief Executive Officer.
  • Dr. Tauber has been centrally involved in virtually every significant dry eye development project during the past 25 years.